← FDA DRUG APPROVALS

FDA ANDA · ANDA090379

BUDESONIDE

Sponsor: BARR LABS DIV TEVA

APPLICATION
ANDA090379
TYPE
ANDA
ORIGINAL APPROVAL
2014-04-02
LATEST ACTION
2014-04-02
ROUTE
ORAL
DOSAGE FORM
CAPSULE, DELAYED RELEASE
MARKETING STATUS
Discontinued

Products

BUDESONIDEDiscontinued
BUDESONIDE 3MG · CAPSULE, DELAYED RELEASE · ORAL

Approval history

2014-04-02OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →